1stBiome ApS

1stBiome is a gut-focused platform company engineering beneficial microbes to reduce low-grade inflammation and support metabolic health and longevity.

The 1stBiome platform is designed to address key biological drivers of chronic disease and aging through targeted modulation of the gut:

• Reduction of endotoxins and oxidative stress in the colon
• Shaping the microbiome toward a healthier, more resilient composition
• Improved appetite control and metabolic signaling
• Support for longevity by reducing inflammation-driven biological stress over time

This platform enables the development of multiple gut-targeted products built on a shared scientific foundation.